TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SEPN

Septerna, Inc.

Healthcare · Biotechnology · —

38.10$ -0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SEPN
Line item 2022 2023 2024 2025
– +262.3% +248.9% +30.6%
– +253.3% +216.7% +15.2%
– +189.1% +169.2% -49.3%
– +189.1% +296.6% +11.4%
– – -95.1% +1,122.4%
– +110.7% -78.4% +486.9%
– +24.7% +85.8% +576.6%
– – – +19.5%
– -14.1% +21.4% +221.3%
– – – -9.1%
– – – –
– +0.0% +90.8% +19.0%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?